In NSCLC, dysregulation of the c-MET signal-mediated growth, death, and migration of the cells could be achieved through c-MET overexpression, amplification, mutation, or hepatocyte growth factor−mediated NSCLC activation (Smyth et al., 2014). This evidence concerns the gene MET and non-small cell lung carcinoma.